Analysis of Demographics, Clinicopathological Features, and Treatment Approaches for Oral Squamous Cell Carcinoma Patients at a Johannesburg Academic Hospital: A Five-Year Retrospective Study - Top-Institutions - MDSpire

Analysis of Demographics, Clinicopathological Features, and Treatment Approaches for Oral Squamous Cell Carcinoma Patients at a Johannesburg Academic Hospital: A Five-Year Retrospective Study

  • By

  • Gal Feller

  • Daniel Mmereki

  • Faiza Mahomed

  • Razia AG Khammissa

  • Duvern Ramiah

  • November 22, 2025

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Head and Neck Oncology
    • Radiation Oncology
    • Surgical Oncology

  • #2

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Head and Neck Oncology
    • Radiation Oncology
    • Medical Oncology

  • #3

    University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical Center

    Dallas, TX

    Key Differentiators

    • Head and Neck Oncology
    • Radiation Oncology

  • #4

    University of the Witwatersrand / Charlotte Maxeke Johannesburg Academic Hospital
    University of the Witwatersrand / Charlotte Maxeke Johannesburg Academic Hospital

    Johannesburg, Gauteng

    Key Differentiators

    • Radiation Oncology
    • Head and Neck Oncology

  • #5

    Royal Marsden Hospital
    Royal Marsden Hospital

    London, England

    Key Differentiators

    • Head and Neck Oncology
    • Radiation Oncology

Original Source(s)

Analysis of Demographics, Clinicopathological Features, and Treatment Approaches for Oral Squamous Cell Carcinoma Patients at a Johannesburg Academic Hospital: A Five-Year Retrospective Study

  • by Gal Feller, Daniel Mmereki, Faiza Mahomed, Razia AG Khammissa, Duvern Ramiah

  • November 22, 2025

Related Content

Case Report: First description of an intracranial “NET” in ROHHAD syndrome; time to rename to the ROHHAD-NeCT syndrome?

Synthetic short RNA in cancer

Ultra-high-sensitivity next-generation sequencing–based MRD predicts outcome in intensively treated older patients with acute myeloid leukemia: results from the ALFA-1200 cohort